Olga Ornatsky

Ornatsky co-founded DVS Sciences[1] in 2004 (acquired by Fluidigm in 2014 and then renamed to Standard BioTools in 2022[2]) along with Dmitry Bandura, Vladimir Baranov and Scott D. Tanner.

In 1989, she completed her Ph.D. in cell and molecular biology,[3] and worked as a research scientist at the Cardiology Centre studying vascular smooth muscle involvement in atherosclerosis.

She quickly progressed to become senior research associate in the Laboratory of Vascular Biology and Cardiac Surgery at St. Michael's Hospital (Toronto).

Together with the co-founders of DVS Sciences Inc. Scott D. Tanner, Vladimir Baranov and Dmitry Bandura, she helped develop the CyTOF™ Mass Cytometer, for highly multi-parametric single cell analysis at the Department of Chemistry, University of Toronto.

Ornatsky has more than fifteen years of experience in the commercial environment as a senior strategic product application developer and in providing advanced customer/collaborator support.